Entia non sunt multiplicanda praeter necessitate.
William of Ockham (c. 1285-1349), author of the Ockham’s Razor principle.
OCKHAM BIOTECH AND LIFE ARC ANNOUNCE MAJOR COLLABORATIVE FUNDING ARRANGEMENT
Fareham and London, UK: 11 October 2024
Ockham Biotech Limited, a UK-based developer of products for the treatment of cystic fibrosis (CF) and non-CF bronchiectasis (NCFBE) and Life Arc, the major UK medical research charity, have announced a significant collaboration.
This major collaborative funding arrangement will enable Ockham Biotech and Life Arc to undertake research into inhaled heparin derivatives in cystic fibrosis and non-CF bronchiectasis.
For more details, please contact
Andy Short, CEO and Chairman
as@ockhambiotech.com